デフォルト表紙
市場調査レポート
商品コード
1764020

セルハーベスター市場- 世界の産業規模、シェア、動向、機会、予測:タイプ別、用途別、地域別セグメント、競合、2020年~2030年

Cell Harvester Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F


出版日
ページ情報
英文 185 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

セルハーベスター市場- 世界の産業規模、シェア、動向、機会、予測:タイプ別、用途別、地域別セグメント、競合、2020年~2030年
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

セルハーベスターの世界市場は、2024年に32億1,000万米ドルと評価され、2030年には46億3,000万米ドルに達し、CAGR 6.48%で成長すると予測されています。

セルハーベスタは、臨床、研究、治療の現場で使用するために、生物学的材料から細胞を分離・収集するために使用される特殊なシステムです。これらの技術は、再生医療、がん治療、個別化診断など幅広い用途に不可欠です。細胞ベースの治療と生物医学研究の進歩が世界的に加速するにつれて、先進地域でも開発途上地域でもこれらのツールの採用が増加しています。同市場は精密医療や幹細胞治療に対する需要の高まりに後押しされているが、その一方で、高額な装置コストや規制の複雑さ、大規模な細胞ハンドリングに対する技術的な要求に関連する課題とも闘っています。

市場概要
予測期間 2026-2030
市場規模:2024年 32億1,000万米ドル
市場規模:2030年 46億3,000万米ドル
CAGR:2025年~2030年 6.48%
急成長セグメント 変位コレクター
最大市場 北米

市場促進要因

ヘルスケア産業の成長

主な市場課題

機器と処置の高コスト

主要市場動向

再生医療と個別化医療の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のセルハーベスター市場に与える影響

第5章 世界のセルハーベスター市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別(変位コレクター、治療コレクター)
    • 用途別(細胞増殖アッセイ、混合リンパ球培養(MLC)アッセイ、受容体結合アッセイ、一本鎖テンプレートDNA採取、その他)
    • 地域別
    • 企業別(2024)
  • 市場マップ

第6章 北米のセルハーベスター市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のセルハーベスター市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のセルハーベスター市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のセルハーベスター市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのセルハーベスター市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 混乱:紛争、パンデミック、貿易障壁

第14章 世界のセルハーベスター市場:SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Human Med AG
  • ADS Biotec Inc.
  • PerkinElmer Inc.
  • Cytiva
  • TERUMO BCT, INC.
  • Esco Micro Pte. Ltd.
  • Gasser Apparatebau und Laborzubehor
  • Sartorius AG
  • Cox Scientific Ltd.
  • Pall Corporation

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 5060

The Global Cell Harvester Market was valued at USD 3.21 Billion in 2024 and is projected to reach USD 4.63 Billion by 2030, growing at a CAGR of 6.48%. Cell harvesters are specialized systems used to isolate and collect cells from biological materials for use in clinical, research, and therapeutic settings. These technologies are integral to a wide range of applications, including regenerative medicine, cancer treatment, and personalized diagnostics. As advancements in cell-based therapies and biomedical research accelerate globally, both developed and developing regions are witnessing increased adoption of these tools. The market is being propelled by growing demand for precision medicine and stem cell therapies, even as it contends with challenges related to high equipment costs, regulatory complexity, and the technical demands of large-scale cell handling.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.21 Billion
Market Size 2030USD 4.63 Billion
CAGR 2025-20306.48%
Fastest Growing SegmentDisplacement Collector
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The global expansion of the healthcare industry is a key factor driving growth in the cell harvester market. With annual revenues surpassing USD 4 trillion, the healthcare sector is undergoing significant evolution, particularly in pharmaceuticals and biotechnology, which together contribute approximately USD 850 billion. Medical technology and diagnostics follow closely, accounting for more than USD 400 billion. This expansive growth is translating into increased investments in advanced medical equipment-including cell harvesting systems-particularly in areas such as precision medicine and regenerative therapies. As healthcare systems in both developed and emerging economies adopt innovative treatment approaches, the need for efficient and reliable cell harvesting tools continues to rise across clinical and research domains.

Key Market Challenges

High Cost of Devices and Procedures

A significant obstacle to broader market adoption is the high cost associated with cell harvesting devices and their related procedures. Devices intended for clinical-grade cell extraction often incorporate advanced features such as full automation, closed-loop systems, and sterile processing capabilities, all of which contribute to higher upfront and operational costs. These financial demands can be prohibitive for smaller healthcare institutions, research labs, and mid-sized biopharmaceutical firms, especially in cost-sensitive regions. Additional expenditures related to equipment setup, maintenance, operator training, and consumables further increase the economic burden. In many developing markets, constrained healthcare budgets limit the accessibility and deployment of advanced biotechnology solutions, posing a barrier to growth.

Key Market Trends

Advancements in Regenerative & Personalized Medicine

The accelerating progress in regenerative and personalized medicine is a pivotal trend shaping the global cell harvester market. These fields rely on the extraction and preparation of patient-specific cells for therapies aimed at tissue repair, organ regeneration, and immune modulation. Stem cell-based interventions, including the use of embryonic, adult, and induced pluripotent stem cells, require precise harvesting techniques to ensure cell viability and therapeutic efficacy. As the demand for autologous treatments grows, particularly in oncology and orthopedics, the need for advanced, minimally invasive, and automated harvesting systems has intensified. Adoption of closed-system and scalable cell harvesters is increasing, as these technologies offer enhanced sterility, reproducibility, and compliance with regulatory standards, aligning with the growing emphasis on individualized medicine.

Key Market Players

  • Human Med AG
  • ADS Biotec Inc.
  • PerkinElmer Inc.
  • Cytiva
  • TERUMO BCT, INC.
  • Esco Micro Pte. Ltd.
  • Gasser Apparatebau und Laborzubehor
  • Sartorius AG
  • Cox Scientific Ltd.
  • Pall Corporation

Report Scope

In this report, the Global Cell Harvester Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Harvester Market, By Type:

  • Displacement Collector
  • Therapy Collector

Cell Harvester Market, By Application:

  • Cell Proliferation Assays
  • Mixed Lymphocyte Culture (MLC) Assays
  • Receptor-Binding Assays
  • Single-Stranded Template DNA Harvesting
  • Others

Cell Harvester Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Harvester Market.

Available Customizations:

Global Cell Harvester Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Cell Harvester Market

5. Global Cell Harvester Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Displacement Collector, Therapy Collector)
    • 5.2.2. By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Cell Harvester Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Harvester Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Cell Harvester Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Cell Harvester Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Cell Harvester Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Cell Harvester Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Cell Harvester Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Cell Harvester Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Cell Harvester Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Cell Harvester Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Cell Harvester Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Harvester Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Cell Harvester Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Cell Harvester Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Cell Harvester Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Cell Harvester Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Cell Harvester Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Harvester Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Cell Harvester Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Cell Harvester Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Cell Harvester Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Harvester Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Cell Harvester Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Cell Harvester Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Cell Harvester Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Human Med AG
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. ADS Biotec Inc.
  • 16.3. PerkinElmer Inc.
  • 16.4. Cytiva
  • 16.5. TERUMO BCT, INC.
  • 16.6. Esco Micro Pte. Ltd.
  • 16.7. Gasser Apparatebau und Laborzubehor
  • 16.8. Sartorius AG
  • 16.9. Cox Scientific Ltd.
  • 16.10. Pall Corporation

17. Strategic Recommendations

18. About Us & Disclaimer